Ohio State Navbar

Our Team

Jose G. Bazan, MD


 

 

 

 

Assistant Professor, Department of Radiation Oncology

 

 

 

 


Memberships

  • 2009-Present: American Society of Therapeutic Radiation Oncolgy.
  • 2015-2018: NRG Breast Committee Member, 3 Year Term.
  • 2013-Present: Residency Admissions, Department of Radiation Oncology, The Ohio State University.

Journal Reviewer

  • 2015-Present: PLOS One
  • 2015-Present: Clinical Lung Cancer
  • 2014-Present: Disease of tire Colon and Rectum
  • 2013-Present: International Journal of Radiation Oncology. Biology, Physics
  • 2012-Present: Lung Cancer
  • 2010-Present: Cancer

Publications

 

  • Rong Y, Bazan JG, Sekhon A, Haglund K, Welliver M, Williams T. Minim11l inter-fractional fiducial migration during image­ guided lung ster.:otactic body radiotherapy using cora nitinol-gold fiducials. PLOS One, in press.
  • Rong Y, Zuo L, Bazan JG.  R11diotherapy treatment for nonmelanoma skin cancer (2015). Submitted to: Expert Rev Anticancer
  • Rong Y, Zuo L, Bazan JG.  R11diotherapy treatment for nonmelanoma skin cancer (2015). Submitted to: Expert Rev Anticancer Ther., 2015 May 8:1-12 (Epub ahead of print]
  • Osmundson EC, Wu Y, Luxton G, Bazan JG, Koong AC, Chang DT. Predictors oftoxicity associated with SBRT to the central hepatobiliary tract. lnt Journal of Radiation Oncology. Biology. Physics.2015 April I ; 91(5):986-94
  • Novello S, Asamura H, Bazan JG, Carbone D.Goldstraw P, Grunewald D, VAnsteenkiste J. Early stage lung cancer: 40's Anniversary (2014). Journal ofThoracic Oncology, 2014 Oct;9(10):1434-42.
  • Bazan JG, White JR.  Imaging of the axilla prior to pre-operative chemotherapy: implications for post-mastectomy radiation (2014). Cancer. 2015 Apr 15; 121(8): 1187-94..
  • Bazan JG, Chang P, Balog R, D'Andrea A, Shaler T, Lin H, LeeS, Harrison T, Shura L, Schoen L, Knox SJ, Cooper DE. Novel human radiation exposure biomarker panel applicable for population triage (2014 ). International Journal of Radiation Oncology. Biology. Physics, 2014 Nov I; 90(3): 612-9.
  • Bazan JG,  Luxton G, Kozak MM, Anderson EM, Hancock SL, Kapp DS, Kidd EA, Koong AC, Chang DT. Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic IMRT (2013).  International Journal of Radiation OncologyBiology, Physics, 87(5): 983-91.
  • Cheng J, Bazan JG, Wu JK, Wu, CJ, Koong AC, Chang. DT.  Lumbosacral spine and bone cavity modeling of acute hematologic toxicity in patients treated with IMRT for squamous cell carcinoma of the anal canal (2014).  Practical Radiation Oncology, 4(3): 198-206.
  • Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy (2012).  Lung Cancer. 78(32) 19-24.
  • Bazan JG. Koong AC, Kapp OS, Quon A, Graves EE, Loo BW, Chang DT. Metabolic tumor volume predicts for disease progression in patients with squamous cell carcinoma of the anal canal (2013). Journal of Nuclear Medicine. 54(1 ): 27-32.
  • Bazan JG*. Luxton G•, Mok EC, Koong AC, Chang DT. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with IMRT for squamous cell carcinoma of the anal canal (2012).  International Journal of Radiation Oncology. Biology.Physics.84(3): 700-6.
  • Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte Rl, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, Wakelee HA, Loo BW Jr (2011). Tumor volume as a potential imaging-based risk­ stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. Journal of Thoracic Oncology. 6(5), 920-6.
  • Lee P•, Bazan JG*. Lavori PW, Weerasuriya OK, Qoun A, Le QT, Wakelee HA, Graves EE, Loo BW (20 II). Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small cell lung cancer.  Clinical Lung Cance13(1 ): 52-58.
  • Bazan JG, lara W, Hsu A, Kunz PA, Fisher GA, Welton ML, Shelton A, Kapp OS, Koong AC, Goodman KA, Chang DT (2011). Intensity-modulated radiation therapy versus conventional r.1diation therapy for squamous cell carcinoma of the anal canal. Cancer.117(15).3342-51.
  • Bazan JG. King CR. Brooks JD, Srinivas S (2010). Adjuvant docetaxel and abbreviated androgen deprivation therapy in patients with high-risk prostate cancer. The Open  Prostate Cancer Journal. 3, 99-104.